CoLucid Pharmaceuticals' (CLCD) Price Target Raised to $52 at Ladenburg Thalmann

September 6, 2016 9:10 AM EDT
Get Alerts CLCD Hot Sheet
Price: $36.00 -9.32%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade CLCD Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Ladenburg Thalmann maintained a Buy rating on CoLucid Pharmaceuticals (NASDAQ: CLCD) and raised its price target to $52.00 (from $23.00)

For an analyst ratings summary and ratings history on CoLucid Pharmaceuticals click here. For more ratings news on CoLucid Pharmaceuticals click here.

Shares of CoLucid Pharmaceuticals closed at $10.66 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst PT Change, Trader Talk

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment